Skip to main content

Table 3 Three to four months evaluation of 30/15 ratio and sympathetic Skin Response (SSR)

From: The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

  Baseline (n = 31) 3–4 months evaluation (n = 26) Wilcoxon signed ranks test
Mean (SD) Median (Range) Mean (SD) Median (Range) P-value
30/15 ratio 1.13 (0.09) 1.10 (1.00–1.43) 1.10 (0.20) 1.03 (0.89–1.94) 0.016
SSR
 Upper limbs 1.46 (0.34) 1.38 (1.10–3.01) 1.61 (0.45) 1.53 (1.10–3.01) 0.17
 Lower limbs 2.22 (0.42) 2.20 (1.60–3.13) 2.27 (0.47) 2.25 (1.60–3.13) 0.74
  1. SSR sympathetic skin response
  2. Significant p-values are shown in bold